"dapagliflozin" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "dapa-",
        "3": "-gliflozin",
        "nocat": "1",
        "qq1": "of unknown origin",
        "t2": "sodium–glucose cotransporter inhibitor"
      },
      "expansion": "dapa- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From dapa- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "dapagliflozin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English entries with language name categories using raw markup",
          "parents": [
            "Entries with language name categories using raw markup",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -gliflozin",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A drug C₂₁H₂₅ClO₆·C₃H₈O₂·H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Farxiga."
      ],
      "id": "en-dapagliflozin-en-noun-uf2QqUI2",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "blood sugar",
          "blood sugar"
        ],
        [
          "reabsorption",
          "reabsorption"
        ],
        [
          "glucose",
          "glucose"
        ],
        [
          "kidney",
          "kidney"
        ],
        [
          "orally",
          "orally"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug C₂₁H₂₅ClO₆·C₃H₈O₂·H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Farxiga."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "dapagliflozin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌdæp.əɡ.ləˈfloʊ.zɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "dapagliflozin"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "dapa-",
        "3": "-gliflozin",
        "nocat": "1",
        "qq1": "of unknown origin",
        "t2": "sodium–glucose cotransporter inhibitor"
      },
      "expansion": "dapa- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From dapa- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "dapagliflozin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English entries with language name categories using raw markup",
        "English lemmas",
        "English nouns",
        "English terms suffixed with -gliflozin",
        "English uncountable nouns",
        "Pages with 1 entry",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A drug C₂₁H₂₅ClO₆·C₃H₈O₂·H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Farxiga."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "blood sugar",
          "blood sugar"
        ],
        [
          "reabsorption",
          "reabsorption"
        ],
        [
          "glucose",
          "glucose"
        ],
        [
          "kidney",
          "kidney"
        ],
        [
          "orally",
          "orally"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug C₂₁H₂₅ClO₆·C₃H₈O₂·H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Farxiga."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "dapagliflozin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌdæp.əɡ.ləˈfloʊ.zɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "dapagliflozin"
}